EUVIMEDScopri EUVIMED
Crossref

Wound Healing Effect of HDACi Repositioned Molecules in the Therapy for Chronic Wounds Models

Alan Santos-Mena iD, Oscar Gonzalez-Muñiz, Adrian Rodríguez-Carlos, Alejandro Rivas Guerrero, Crisol Rodriguez Mendieta, Yolanda M Jacobo Delgado, Gerardo Sauceda Muñoz, Yvonne Rosenstein, Valentin Trujillo-Paez, Diana Portales-Perez, Luis A de Jesus Gonzalez iD, Renato Calvillo and 3 more

Experimental Dermatology · 2025

DOI: 10.1111/exd.70060 ↗

At a glance

Journal article in Experimental Dermatology, 2025. Written by Alan Santos-Mena and 14 co-authors. Institution: Faculty of Chemical Sciences, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico. Major MEDLINE topics: Wound Healing, Histone Deacetylase Inhibitors. Cited 3 times so far (Crossref); 62 references. Funded by: Consejo Nacional de Ciencia y Tecnología, Instituto Mexicano del Seguro Social, Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Globally, chronic wounds impact the health of millions of people, negatively affecting quality of life and healthcare budgets. Some of the crucial steps and pathways in healing mechanisms are the hypoxic response and the expression of host defence peptides, which are decreased in diseases related to chronic wounds such as diabetes mellitus and cardiovascular diseases. It has been shown that histone deacetylase inhibitors can induce the expression of Host Defence Peptides (HDP) by inducing the stabilisation and activation of hypoxia‐inducible factor 1‐α (HIF‐1α), promoting wound healing pathways, although their high cost and side effects limit clinical research. With the help of bioinformatics tools, we found potential histone deacetylase inhibitor candidates in an FDA‐approved drugs database. The candidates, 1,3‐Diphenylurea (DiPU), 2'‐Aminoacetanilide (Ace), and Tert‐butyl (2‐aminophenyl) carbamate (N‐boc), show wound healing effects in HaCaT cells, increasing cell migration possibly via HIF‐1α, inducing the expression of LL‐37 and vascular endothelial growth factor (VEGF), while in a mouse ring angiogenesis model, Ace and N‐boc have angiogenic effects. In a model of basal primary keratinocytes from donors with diabetes mellitus (DM), without DM, and from Diabetic Foot Ulcers (DFU), it was observed that only DiPU is capable of inducing LL‐37 in all scenarios. There is limited information about histone deacetylase inhibitors and wound healing but in this paper, we observe promising results and a proposed mechanism that involved specifically Histone Deacetylase 1 inhibition (HDAC1).

Subjects

MeSH terms (MEDLINE)

Wound HealingHistone Deacetylase InhibitorsAnimalsHumansHypoxia-Inducible Factor 1, alpha SubunitMiceCell MovementVascular Endothelial Growth Factor ADrug RepositioningAcetanilidesDisease Models, AnimalKeratinocytesCarbamatesCell LineNeovascularization, Physiologic

Author keywords

HDACHIF‐1αchronic woundsepigenetic modificationshost defence peptideswound healing

Substances

Histone Deacetylase InhibitorsHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor AHIF1A protein, humanAcetanilidesCarbamates

Authors and institutions

  • Faculty of Chemical Sciences, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
  • Biomedical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Mexico City, Mexico.
  • General Hospital "Dr. Emilio Varela Lujan" Mexican Institute of Social Security-IMSS, Zacatecas, Mexico.
  • Department of Molecular Medicine and Bioprocesses, Institute of Biotechnology, UNAM Cuernavaca, Cuernavaca, Mexico.
  • General Hospital of Zacatecas "Luz Gonzáles Cosio" Zacatecas, Zacatecas, Mexico.
  • Laboratorio de Inmunotoxicología y Terapéutica Experimental, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Campus UAZ, Siglo XXI, Zacatecas, Mexico.

ORCID profiles: Alan Santos-Mena, Luis A de Jesus Gonzalez, Bruno Rivas-Santiago

Funding

  • Consejo Nacional de Ciencia y Tecnología
  • Instituto Mexicano del Seguro Social
  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Cite

APA

Santos-Mena, A., Gonzalez-Muñiz, O., Rodríguez-Carlos, A., Guerrero, A. R., Mendieta, C. R., Jacobo Delgado, Y. M., Muñoz, G. S., Rosenstein, Y., Trujillo-Paez, V., Portales-Perez, D., de Jesus Gonzalez, L. A., Calvillo, R., Gonzalez-Curiel, I., Vitales-Noyola, M., & Rivas-Santiago, B. (2025). Wound Healing Effect of HDACi Repositioned Molecules in the Therapy for Chronic Wounds Models. Experimental Dermatology. https://doi.org/10.1111/exd.70060

Vancouver

Santos-Mena A, Gonzalez-Muñiz O, Rodríguez-Carlos A, Guerrero AR, Mendieta CR, Jacobo Delgado YM, et al. Wound Healing Effect of HDACi Repositioned Molecules in the Therapy for Chronic Wounds Models. Experimental Dermatology. 2025. doi:10.1111/exd.70060

BibTeX
@article{SantosMena2025,
  author = {Santos-Mena, Alan and Gonzalez-Muñiz, Oscar and Rodríguez-Carlos, Adrian and Guerrero, Alejandro Rivas and Mendieta, Crisol Rodriguez and Jacobo Delgado, Yolanda M and Muñoz, Gerardo Sauceda and Rosenstein, Yvonne and Trujillo-Paez, Valentin and Portales-Perez, Diana and de Jesus Gonzalez, Luis A and Calvillo, Renato and Gonzalez-Curiel, Irma and Vitales-Noyola, Marlen and Rivas-Santiago, Bruno},
  title = {Wound Healing Effect of HDACi Repositioned Molecules in the Therapy for Chronic Wounds Models},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70060}
}
Start for free →